FDA Requests Comments for Risk Assessment on Norovirus in Bivalve Molluscan Shellfish
October 20, 2011
The U.S. Food and Drug Administration (FDA) is undertaking a collaboration with Health Canada, the Canadian Food Inspection Agency, Environment Canada, and Fisheries and Oceans Canada, to conduct a quantitative risk assessment on norovirus in bivalve molluscan shellfish. The risk assessment will focus on contamination of oysters, clams and mussels during growth, harvest, and post-harvest processing and will examine the impact of preventive practices and controls on the level of risk. FDA, on behalf of the collaborative team, is requesting comments, scientific data and information that would assist in the development of the risk assessment.
The deadline for electronic or written submission of comments, scientific data, or information is January 18, 2012. For instructions and more information, please consult Federal Register Docket No. FDA-2011-N-0731, or contact:
Jane M. Van Doren, Ph.D.
Center for Food Safety and Applied Nutrition (HFS – 005)
Food and Drug Administration
5100 Paint Branch Parkway
College Park, MD 20740
Additional Information on Risk Assessments: